The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Recursion Pharmaceuticals leverages AI and machine learning to revolutionize drug discovery, reducing costs and accelerating development, positioning itself as a leader in tech-driven biopharma. The ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...